EuroEspes S.A [EEP] vs Clinica Baviera S.A [CBAV] Detailed Stock Comparison

EuroEspes S.A.

BME
Loading...

Clinica Baviera S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: EuroEspes S.A. wins in 3 metrics, Clinica Baviera S.A. wins in 8 metrics, with 0 ties. Clinica Baviera S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric EuroEspes S.A. Clinica Baviera S.A. Better
P/E Ratio (TTM) N/A 19.77 N/A
Price-to-Book Ratio N/A 7.57 N/A
Debt-to-Equity Ratio 0.70 62.33 EuroEspes S.A.
PEG Ratio N/A 29.55 N/A
EV/EBITDA 20.27 10.30 Clinica Baviera S.A.
Profit Margin (TTM) 88.31% 13.80% EuroEspes S.A.
Operating Margin (TTM) -9.52% 22.22% Clinica Baviera S.A.
EBITDA Margin (TTM) N/A 22.22% N/A
Return on Equity -12.57% 41.02% Clinica Baviera S.A.
Return on Assets (TTM) -4.65% 16.48% Clinica Baviera S.A.
Free Cash Flow (TTM) $-129,985 $46.83M Clinica Baviera S.A.
Dividend Yield N/A 7.97% N/A
1-Year Return 0.00% 49.86% Clinica Baviera S.A.
Price-to-Sales Ratio (TTM) 2.14 2.73 EuroEspes S.A.
Enterprise Value $9.48M $852.77M Clinica Baviera S.A.
EV/Revenue Ratio 3.26 2.80 Clinica Baviera S.A.
Revenue per Share (TTM) N/A $19 N/A
Earnings per Share (Diluted) N/A $2.63 N/A
Beta (Stock Volatility) N/A 0.71 N/A

EuroEspes S.A. vs Clinica Baviera S.A. Stock Performance Analysis

Loading Price Chart...

EEP
CBAV

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
EuroEspes S.A.0.00%0.00%0.00%0.00%0.00%0.00%
Clinica Baviera S.A.-1.14%-0.38%5.69%0.00%17.65%5.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
EuroEspes S.A.0.00%0.00%3.85%-46.53%-59.70%-59.70%
Clinica Baviera S.A.49.86%175.86%290.98%847.18%933.80%933.80%

Performance & Financial Health Analysis: EuroEspes S.A. vs Clinica Baviera S.A.

MetricEEPCBAV
Market Information
Market Cap i€6.22M€832.96M
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i283,308
90 Day Avg. Volume i33,086
Last Close€0.54€52.00
52 Week Range€0.54 - €0.54€33.70 - €56.60
% from 52W High0.00%-8.13%
All-Time High€2.45 (Jan 20, 2014)€56.60 (Feb 06, 2026)
% from All-Time High-77.96%-8.13%
Growth Metrics
Quarterly Revenue GrowthN/A0.11%
Quarterly Earnings GrowthN/A0.13%
Financial Health
Profit Margin (TTM) i0.88%0.14%
Operating Margin (TTM) i-0.10%0.22%
Return on Equity (TTM) i-0.13%0.41%
Debt to Equity (MRQ) i0.7062.33
Cash & Liquidity
Book Value per Share (MRQ)N/A€6.87
Cash per Share (MRQ)N/A€3.14
Operating Cash Flow (TTM) i€-452,958€76.84M
Levered Free Cash Flow (TTM) i€-323,179€40.45M
Dividends
Last 12-Month Dividend Yield iN/A7.97%
Last 12-Month Dividend iN/A€3.14

Valuation & Enterprise Metrics Analysis: EuroEspes S.A. vs Clinica Baviera S.A.

MetricEEP (Dec 19, 2025)CBAV (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A19.77
Forward P/E iN/A29.55
PEG Ratio iN/A29.55
Price to Sales (TTM) i2.142.73
Price to Book (MRQ) iN/A7.57
Market Capitalization
Market Capitalization i€6.22M€832.96M
Enterprise Value i€9.48M€852.77M
Enterprise Value Metrics
Enterprise to Revenue i3.262.80
Enterprise to EBITDA i20.2710.30
Risk & Other Metrics
Beta iN/A0.71
Book Value per Share (MRQ) iN/A€6.87

Financial Statements Comparison: EuroEspes S.A. vs Clinica Baviera S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEEP (2024)CBAV (2025)
Revenue/Sales i2.91M301.78M
Cost of Goods Sold i340,14833.98M
COGS % of Revenue i11.7%11.3%
Gross Profit i2.57M267.81M
Gross Margin i88.3%88.7%
Research & Development iN/AN/A
Operating Income (EBIT) i-270,46860.64M
Operating Margin i-9.3%20.1%
EBITDA i467,44686.02M
EBITDA Margin i16.1%28.5%
Pre-Tax Income i-319,34360.11M
Pre-Tax Income % of Revenue i-11.0%19.9%
Income Tax i3,86017.18M
Income Tax % of Revenue i0.1%5.7%
Net Income (Profit) i-323,20342.94M
Profit Margin i-11.1%14.2%

Balance Sheet & Liquidity Metrics

MetricEEP (2024)CBAV (2025)
Cash & Equivalents i217,3705.59M
Total Current Assets i631,81159.34M
Total Current Assets % of Revenue i21.7%19.7%
Total Current Liabilities i681,39161.47M
Total Current Liabilities % of Revenue i23.4%20.4%
Long-Term Debt i3.29M57.48M
Long-Term Debt % of Revenue i113.2%19.0%
Total Shareholders Equity i2.57M110.96M
Retained Earnings i-323,17942.06M
Retained Earnings % of Revenue i-11.1%13.9%
Property, Plant & Equipment i10.42M142.87M

Cash Flow Statement Comparison

MetricEEP (2024)CBAV (2025)
Operating Cash Flow i-452,95861.58M
Operating Cash Flow % of Revenue i-15.6%20.4%
Capital Expenditures i-1,804-30.01M
Free Cash Flow i-129,98546.83M
FCF Margin i-4.5%15.5%
Debt Repayment i-370,613-2.27M
Common Stock Repurchase iN/A-2.39M

Short Interest & Institutional Ownership Analysis

MetricEEPCBAV
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i11.61M16.02M
Float Shares iN/A2.19M
% Held by Insiders iN/A81.55%
% Held by Institutions iN/A7.91%
% Held by Public iN/A10.54%

Dividend Analysis & Yield Comparison: EuroEspes S.A. vs Clinica Baviera S.A.

MetricEEPCBAV
Last 12-Month Dividend iN/A€3.14
Last 12-Month Dividend Yield iN/A7.97%
3-Year Avg Annual Dividend iN/A€1.48
3-Year Avg Dividend Yield iN/A4.15%
3-Year Total Dividends iN/A€4.44
Ex-Dividend DateN/AJun 11, 2025